• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

American Shared responds to FTC request

Article

Mobile imaging provider American Shared Hospital Services of San Francisco reported June 1 that the Federal Trade Commission has requested additional information about the company's intended sale of its medical imaging assets to Alliance Imaging.

Mobile imaging provider American Shared Hospital Services of San Francisco reported June 1 that the Federal Trade Commission has requested additional information about the company's intended sale of its medical imaging assets to Alliance Imaging. American Shared declined to comment on the nature of the FTC's request, or to say whether it would delay the close of the transaction, anticipated for the third quarter of 1998.

Industry watchers question whether the request arises out of Alliance's aggressive acquisitions of other mobile imaging companies, which has made the Anaheim, CA-based imaging services provider by far the largest player in the mobile market. Alliance recently acquired Mobile Technology of Los Angeles for an estimated $100 million, and now runs 180 mobile MRI systems throughout the U.S.

Alliance announced March 12 its intent to purchase American Shared's mobile routes for $13.6 million, and agreed to assume the company's $26.1 million debt (SCAN 3/18/98). American Shared is one of the largest remaining independent mobile companies, with 30 MRI and 15 CT routes across the U.S.

Recent Videos
Computed Tomography Study Shows Emergence of Silicosis in Engineered Stone Countertop Workers
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
Related Content
© 2024 MJH Life Sciences

All rights reserved.